IBDEI0Z9 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17190,1,4,0)
 ;;=4^V16.51
 ;;^UTILITY(U,$J,358.3,17190,1,5,0)
 ;;=5^FAM.HX-MAL. NEOP. KIDNEY
 ;;^UTILITY(U,$J,358.3,17190,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,17191,0)
 ;;=V16.59^^88^1050^9
 ;;^UTILITY(U,$J,358.3,17191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17191,1,4,0)
 ;;=4^V16.59
 ;;^UTILITY(U,$J,358.3,17191,1,5,0)
 ;;=5^FAM.HX-MAL. NEOP. OTH URIN
 ;;^UTILITY(U,$J,358.3,17191,2)
 ;;=^321503
 ;;^UTILITY(U,$J,358.3,17192,0)
 ;;=V16.6^^88^1050^12
 ;;^UTILITY(U,$J,358.3,17192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17192,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,17192,1,5,0)
 ;;=5^FAMILY HX-LEUKEMIA
 ;;^UTILITY(U,$J,358.3,17192,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,17193,0)
 ;;=V16.7^^88^1050^7
 ;;^UTILITY(U,$J,358.3,17193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17193,1,4,0)
 ;;=4^V16.7
 ;;^UTILITY(U,$J,358.3,17193,1,5,0)
 ;;=5^FAM HX-LYMPH NEOPLAS NEC
 ;;^UTILITY(U,$J,358.3,17193,2)
 ;;=^295299
 ;;^UTILITY(U,$J,358.3,17194,0)
 ;;=V16.8^^88^1050^13
 ;;^UTILITY(U,$J,358.3,17194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17194,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,17194,1,5,0)
 ;;=5^FAMILY HX-MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,17194,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,17195,0)
 ;;=V17.89^^88^1051^1
 ;;^UTILITY(U,$J,358.3,17195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17195,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,17195,1,5,0)
 ;;=5^FAM HX MUSCULOSK DIS NEC
 ;;^UTILITY(U,$J,358.3,17195,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,17196,0)
 ;;=V17.49^^88^1051^2
 ;;^UTILITY(U,$J,358.3,17196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17196,1,4,0)
 ;;=4^V17.49
 ;;^UTILITY(U,$J,358.3,17196,1,5,0)
 ;;=5^FAM HX-CARDIOVAS DIS NEC
 ;;^UTILITY(U,$J,358.3,17196,2)
 ;;=^295306
 ;;^UTILITY(U,$J,358.3,17197,0)
 ;;=V17.6^^88^1051^3
 ;;^UTILITY(U,$J,358.3,17197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17197,1,4,0)
 ;;=4^V17.6
 ;;^UTILITY(U,$J,358.3,17197,1,5,0)
 ;;=5^FAM HX-CHR RESP COND NEC
 ;;^UTILITY(U,$J,358.3,17197,2)
 ;;=^295308
 ;;^UTILITY(U,$J,358.3,17198,0)
 ;;=V17.3^^88^1051^4
 ;;^UTILITY(U,$J,358.3,17198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17198,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,17198,1,5,0)
 ;;=5^FAM HX-ISCHEM HEART DIS
 ;;^UTILITY(U,$J,358.3,17198,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,17199,0)
 ;;=V17.2^^88^1051^5
 ;;^UTILITY(U,$J,358.3,17199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17199,1,4,0)
 ;;=4^V17.2
 ;;^UTILITY(U,$J,358.3,17199,1,5,0)
 ;;=5^FAM HX-NEUROLOG DIS NEC
 ;;^UTILITY(U,$J,358.3,17199,2)
 ;;=^295304
 ;;^UTILITY(U,$J,358.3,17200,0)
 ;;=V17.0^^88^1051^6
 ;;^UTILITY(U,$J,358.3,17200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17200,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,17200,1,5,0)
 ;;=5^FAM HX-PSYCHIATRIC COND
 ;;^UTILITY(U,$J,358.3,17200,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,17201,0)
 ;;=V17.7^^88^1051^7
 ;;^UTILITY(U,$J,358.3,17201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17201,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,17201,1,5,0)
 ;;=5^FAMILY HX-ARTHRITIS
 ;;^UTILITY(U,$J,358.3,17201,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,17202,0)
 ;;=V17.5^^88^1051^8
 ;;^UTILITY(U,$J,358.3,17202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17202,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,17202,1,5,0)
 ;;=5^FAMILY HX-ASTHMA
 ;;^UTILITY(U,$J,358.3,17202,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,17203,0)
 ;;=V17.1^^88^1051^9
 ;;^UTILITY(U,$J,358.3,17203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17203,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,17203,1,5,0)
 ;;=5^FAMILY HX-STROKE
 ;;^UTILITY(U,$J,358.3,17203,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,17204,0)
 ;;=V15.1^^88^1052^6
 ;;
 ;;$END ROU IBDEI0Z9
